Prolongation of survival of guinea pig heart grafts in cobra venom factor-treated rats by splenectomy : no additional effect of cyclosporine

In recent years, the study of xenotransplantation has met with promising results. Long-term survival of concordant grafts has been reported in small animal models as well as in monkeys. In contrast, the survival times of discordant vascularized grafts are still poor. The reported survival of a pig h...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transplantation 1995-12, Vol.60 (11), p.1350-1353
Hauptverfasser: SCHERINGA, M, SCHRAA, E. O, BOUWMAN, E, VAN DIJK, H, MELIEF, M. J, IJZERMANS, J. N. M, MARQUET, R. L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1353
container_issue 11
container_start_page 1350
container_title Transplantation
container_volume 60
creator SCHERINGA, M
SCHRAA, E. O
BOUWMAN, E
VAN DIJK, H
MELIEF, M. J
IJZERMANS, J. N. M
MARQUET, R. L
description In recent years, the study of xenotransplantation has met with promising results. Long-term survival of concordant grafts has been reported in small animal models as well as in monkeys. In contrast, the survival times of discordant vascularized grafts are still poor. The reported survival of a pig heart in a monkey of 22 days by Alexandre et al. in 1989 is the longest survival reported today. The results obtained in the guinea pig (GP*) to rat combination underscore the hardness of the discordant problem. The longest survival time of GP hearts in rat recipients reported today is 7 days. This was achieved by treating the rats with cobra venom factor in combination with splenectomy (Spx) and deoxyspergualin. It was argued that the additional effect of deoxyspergualin could be ascribed to inhibition of B cells producing anti-GP antibodies. We were interested to know whether partial antibody depletion in complement-deficient rats indeed results in prolongation of GP hearts. Pretransplant Spx was performed to reduce antibody titers and cobra venom factor (CVF) to deplete complement activity. We were further interested to see whether T cells were involved in the rejection of GP hearts in the absence of hyperacute rejection. Although it is generally accepted that T cells are of no importance in hyperacute rejection, their role has not been established in the rejection of discordant grafts in a situation where hyperacute rejection is precluded. Therefore, we have studied the role of T cells in the rejection of GP heart grafts in complement-depleted, splenectomized rats by treating these rats additionally with cyclosporine (CsA).
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_77749269</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77749269</sourcerecordid><originalsourceid>FETCH-LOGICAL-p266t-e3982122e725dae0c40b60869e306541aa3a7921b03645503b086d1e15866f643</originalsourceid><addsrcrecordid>eNqFkE1LxDAQhoso67r6E4QcxFshH03SehPxCxb0oOcybac10iY1aRf6H_zRZnHx6mkGnof3ZeYoWTMpslTRnB4na0ozljIh9GlyFsInpVQKrVfJKpdcRm-dfL961zvbwWScJa4lYfY7s4N-v3ezsQhkNB35QPAT6Ty0UyDGktpVHsgOrRtIC_XkfDp5hAkb4iEq1ULC2KPFiIaF3BDrCDSN2dfEcGzbSPYd9VL3LozOx6rz5KSFPuDFYW6S94f7t7undPvy-Hx3u01HrtSUoihyzjhHzWUDSOuMVvFgVaCgSmYMQIAuOKuoUJmUVFQRNgyZzJVqVSY2yfVv7ujd14xhKgcTaux7sOjmUGqts4Kr4l-RaZprJvfi5UGcqwGbcvRmAL-Uhz9HfnXgEGroWw-2NuFP40XGCpmLH8o9h_E</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17087159</pqid></control><display><type>article</type><title>Prolongation of survival of guinea pig heart grafts in cobra venom factor-treated rats by splenectomy : no additional effect of cyclosporine</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>SCHERINGA, M ; SCHRAA, E. O ; BOUWMAN, E ; VAN DIJK, H ; MELIEF, M. J ; IJZERMANS, J. N. M ; MARQUET, R. L</creator><creatorcontrib>SCHERINGA, M ; SCHRAA, E. O ; BOUWMAN, E ; VAN DIJK, H ; MELIEF, M. J ; IJZERMANS, J. N. M ; MARQUET, R. L</creatorcontrib><description>In recent years, the study of xenotransplantation has met with promising results. Long-term survival of concordant grafts has been reported in small animal models as well as in monkeys. In contrast, the survival times of discordant vascularized grafts are still poor. The reported survival of a pig heart in a monkey of 22 days by Alexandre et al. in 1989 is the longest survival reported today. The results obtained in the guinea pig (GP*) to rat combination underscore the hardness of the discordant problem. The longest survival time of GP hearts in rat recipients reported today is 7 days. This was achieved by treating the rats with cobra venom factor in combination with splenectomy (Spx) and deoxyspergualin. It was argued that the additional effect of deoxyspergualin could be ascribed to inhibition of B cells producing anti-GP antibodies. We were interested to know whether partial antibody depletion in complement-deficient rats indeed results in prolongation of GP hearts. Pretransplant Spx was performed to reduce antibody titers and cobra venom factor (CVF) to deplete complement activity. We were further interested to see whether T cells were involved in the rejection of GP hearts in the absence of hyperacute rejection. Although it is generally accepted that T cells are of no importance in hyperacute rejection, their role has not been established in the rejection of discordant grafts in a situation where hyperacute rejection is precluded. Therefore, we have studied the role of T cells in the rejection of GP heart grafts in complement-depleted, splenectomized rats by treating these rats additionally with cyclosporine (CsA).</description><identifier>ISSN: 0041-1337</identifier><identifier>EISSN: 1534-6080</identifier><identifier>PMID: 8525534</identifier><identifier>CODEN: TRPLAU</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott</publisher><subject>Animals ; Biological and medical sciences ; Complement Activation - drug effects ; Complement Inactivator Proteins - pharmacology ; Cyclosporine - administration &amp; dosage ; Elapid Venoms - administration &amp; dosage ; Female ; Graft Rejection - immunology ; Graft Survival ; Guanidines - pharmacology ; Guinea Pigs ; Heart Transplantation - immunology ; Heart Transplantation - pathology ; Immunosuppressive Agents - administration &amp; dosage ; Male ; Medical sciences ; Rats ; Rats, Inbred Lew ; Splenectomy ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the heart ; T-Lymphocytes - immunology ; Transplantation, Heterologous</subject><ispartof>Transplantation, 1995-12, Vol.60 (11), p.1350-1353</ispartof><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2941958$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8525534$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SCHERINGA, M</creatorcontrib><creatorcontrib>SCHRAA, E. O</creatorcontrib><creatorcontrib>BOUWMAN, E</creatorcontrib><creatorcontrib>VAN DIJK, H</creatorcontrib><creatorcontrib>MELIEF, M. J</creatorcontrib><creatorcontrib>IJZERMANS, J. N. M</creatorcontrib><creatorcontrib>MARQUET, R. L</creatorcontrib><title>Prolongation of survival of guinea pig heart grafts in cobra venom factor-treated rats by splenectomy : no additional effect of cyclosporine</title><title>Transplantation</title><addtitle>Transplantation</addtitle><description>In recent years, the study of xenotransplantation has met with promising results. Long-term survival of concordant grafts has been reported in small animal models as well as in monkeys. In contrast, the survival times of discordant vascularized grafts are still poor. The reported survival of a pig heart in a monkey of 22 days by Alexandre et al. in 1989 is the longest survival reported today. The results obtained in the guinea pig (GP*) to rat combination underscore the hardness of the discordant problem. The longest survival time of GP hearts in rat recipients reported today is 7 days. This was achieved by treating the rats with cobra venom factor in combination with splenectomy (Spx) and deoxyspergualin. It was argued that the additional effect of deoxyspergualin could be ascribed to inhibition of B cells producing anti-GP antibodies. We were interested to know whether partial antibody depletion in complement-deficient rats indeed results in prolongation of GP hearts. Pretransplant Spx was performed to reduce antibody titers and cobra venom factor (CVF) to deplete complement activity. We were further interested to see whether T cells were involved in the rejection of GP hearts in the absence of hyperacute rejection. Although it is generally accepted that T cells are of no importance in hyperacute rejection, their role has not been established in the rejection of discordant grafts in a situation where hyperacute rejection is precluded. Therefore, we have studied the role of T cells in the rejection of GP heart grafts in complement-depleted, splenectomized rats by treating these rats additionally with cyclosporine (CsA).</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Complement Activation - drug effects</subject><subject>Complement Inactivator Proteins - pharmacology</subject><subject>Cyclosporine - administration &amp; dosage</subject><subject>Elapid Venoms - administration &amp; dosage</subject><subject>Female</subject><subject>Graft Rejection - immunology</subject><subject>Graft Survival</subject><subject>Guanidines - pharmacology</subject><subject>Guinea Pigs</subject><subject>Heart Transplantation - immunology</subject><subject>Heart Transplantation - pathology</subject><subject>Immunosuppressive Agents - administration &amp; dosage</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Rats</subject><subject>Rats, Inbred Lew</subject><subject>Splenectomy</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the heart</subject><subject>T-Lymphocytes - immunology</subject><subject>Transplantation, Heterologous</subject><issn>0041-1337</issn><issn>1534-6080</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1LxDAQhoso67r6E4QcxFshH03SehPxCxb0oOcybac10iY1aRf6H_zRZnHx6mkGnof3ZeYoWTMpslTRnB4na0ozljIh9GlyFsInpVQKrVfJKpdcRm-dfL961zvbwWScJa4lYfY7s4N-v3ezsQhkNB35QPAT6Ty0UyDGktpVHsgOrRtIC_XkfDp5hAkb4iEq1ULC2KPFiIaF3BDrCDSN2dfEcGzbSPYd9VL3LozOx6rz5KSFPuDFYW6S94f7t7undPvy-Hx3u01HrtSUoihyzjhHzWUDSOuMVvFgVaCgSmYMQIAuOKuoUJmUVFQRNgyZzJVqVSY2yfVv7ujd14xhKgcTaux7sOjmUGqts4Kr4l-RaZprJvfi5UGcqwGbcvRmAL-Uhz9HfnXgEGroWw-2NuFP40XGCpmLH8o9h_E</recordid><startdate>19951215</startdate><enddate>19951215</enddate><creator>SCHERINGA, M</creator><creator>SCHRAA, E. O</creator><creator>BOUWMAN, E</creator><creator>VAN DIJK, H</creator><creator>MELIEF, M. J</creator><creator>IJZERMANS, J. N. M</creator><creator>MARQUET, R. L</creator><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>19951215</creationdate><title>Prolongation of survival of guinea pig heart grafts in cobra venom factor-treated rats by splenectomy : no additional effect of cyclosporine</title><author>SCHERINGA, M ; SCHRAA, E. O ; BOUWMAN, E ; VAN DIJK, H ; MELIEF, M. J ; IJZERMANS, J. N. M ; MARQUET, R. L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p266t-e3982122e725dae0c40b60869e306541aa3a7921b03645503b086d1e15866f643</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Complement Activation - drug effects</topic><topic>Complement Inactivator Proteins - pharmacology</topic><topic>Cyclosporine - administration &amp; dosage</topic><topic>Elapid Venoms - administration &amp; dosage</topic><topic>Female</topic><topic>Graft Rejection - immunology</topic><topic>Graft Survival</topic><topic>Guanidines - pharmacology</topic><topic>Guinea Pigs</topic><topic>Heart Transplantation - immunology</topic><topic>Heart Transplantation - pathology</topic><topic>Immunosuppressive Agents - administration &amp; dosage</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Rats</topic><topic>Rats, Inbred Lew</topic><topic>Splenectomy</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the heart</topic><topic>T-Lymphocytes - immunology</topic><topic>Transplantation, Heterologous</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SCHERINGA, M</creatorcontrib><creatorcontrib>SCHRAA, E. O</creatorcontrib><creatorcontrib>BOUWMAN, E</creatorcontrib><creatorcontrib>VAN DIJK, H</creatorcontrib><creatorcontrib>MELIEF, M. J</creatorcontrib><creatorcontrib>IJZERMANS, J. N. M</creatorcontrib><creatorcontrib>MARQUET, R. L</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SCHERINGA, M</au><au>SCHRAA, E. O</au><au>BOUWMAN, E</au><au>VAN DIJK, H</au><au>MELIEF, M. J</au><au>IJZERMANS, J. N. M</au><au>MARQUET, R. L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prolongation of survival of guinea pig heart grafts in cobra venom factor-treated rats by splenectomy : no additional effect of cyclosporine</atitle><jtitle>Transplantation</jtitle><addtitle>Transplantation</addtitle><date>1995-12-15</date><risdate>1995</risdate><volume>60</volume><issue>11</issue><spage>1350</spage><epage>1353</epage><pages>1350-1353</pages><issn>0041-1337</issn><eissn>1534-6080</eissn><coden>TRPLAU</coden><abstract>In recent years, the study of xenotransplantation has met with promising results. Long-term survival of concordant grafts has been reported in small animal models as well as in monkeys. In contrast, the survival times of discordant vascularized grafts are still poor. The reported survival of a pig heart in a monkey of 22 days by Alexandre et al. in 1989 is the longest survival reported today. The results obtained in the guinea pig (GP*) to rat combination underscore the hardness of the discordant problem. The longest survival time of GP hearts in rat recipients reported today is 7 days. This was achieved by treating the rats with cobra venom factor in combination with splenectomy (Spx) and deoxyspergualin. It was argued that the additional effect of deoxyspergualin could be ascribed to inhibition of B cells producing anti-GP antibodies. We were interested to know whether partial antibody depletion in complement-deficient rats indeed results in prolongation of GP hearts. Pretransplant Spx was performed to reduce antibody titers and cobra venom factor (CVF) to deplete complement activity. We were further interested to see whether T cells were involved in the rejection of GP hearts in the absence of hyperacute rejection. Although it is generally accepted that T cells are of no importance in hyperacute rejection, their role has not been established in the rejection of discordant grafts in a situation where hyperacute rejection is precluded. Therefore, we have studied the role of T cells in the rejection of GP heart grafts in complement-depleted, splenectomized rats by treating these rats additionally with cyclosporine (CsA).</abstract><cop>Hagerstown, MD</cop><pub>Lippincott</pub><pmid>8525534</pmid><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0041-1337
ispartof Transplantation, 1995-12, Vol.60 (11), p.1350-1353
issn 0041-1337
1534-6080
language eng
recordid cdi_proquest_miscellaneous_77749269
source MEDLINE; Journals@Ovid Complete
subjects Animals
Biological and medical sciences
Complement Activation - drug effects
Complement Inactivator Proteins - pharmacology
Cyclosporine - administration & dosage
Elapid Venoms - administration & dosage
Female
Graft Rejection - immunology
Graft Survival
Guanidines - pharmacology
Guinea Pigs
Heart Transplantation - immunology
Heart Transplantation - pathology
Immunosuppressive Agents - administration & dosage
Male
Medical sciences
Rats
Rats, Inbred Lew
Splenectomy
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the heart
T-Lymphocytes - immunology
Transplantation, Heterologous
title Prolongation of survival of guinea pig heart grafts in cobra venom factor-treated rats by splenectomy : no additional effect of cyclosporine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T21%3A32%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prolongation%20of%20survival%20of%20guinea%20pig%20heart%20grafts%20in%20cobra%20venom%20factor-treated%20rats%20by%20splenectomy%20:%20no%20additional%20effect%20of%20cyclosporine&rft.jtitle=Transplantation&rft.au=SCHERINGA,%20M&rft.date=1995-12-15&rft.volume=60&rft.issue=11&rft.spage=1350&rft.epage=1353&rft.pages=1350-1353&rft.issn=0041-1337&rft.eissn=1534-6080&rft.coden=TRPLAU&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E77749269%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17087159&rft_id=info:pmid/8525534&rfr_iscdi=true